Objective
The purpose of this study was to investigate the effect of Ebselen on the proliferation and migration of bladder cancer cells and to attempt to find the regulatory mechanism to provide a new theoretical basis for the treatment of bladder cancer.
Materials and Methods
The effects of different concentrations (40 µM, 50 µM and 60 ΜM) of Ebs on the activity, cell cycle, proliferation and migration as well as the evolution of the expression of apoptosis and autophagy-related proteins in T24 and UMUC-3 cell lines were studied. The inhibitory effect of Ebselen on the proliferation and migration of bladder cancer cells was also verified at the animal level.
Results
The results showed that T24 and UMUC-3 cells significantly reduced cell activity, proliferation ability and migration ability, and the proportion of the G2/M stage was increased considerably. The expression of pro-apoptosis-related protein BAX, cleaved-caspase-3/caspase-3 and autophagy-related proteins Beclin-1 and LC3II/Ⅰ were significantly increased. The expression levels of the proteins BCL-XL, P62, P-PI3K, P-AKT, P-mTOR and STAT3 were significantly decreased. In addition, the tumour volume of mice in the Ebs group was reduced considerably, and the results of H&E staining and immunohistochemical staining also indicated that inflammatory infiltrating cells were significantly reduced in the Ebs group. Meanwhile, the number of cells positive for Ki-67, P63 and STAT3 proteins was significantly decreased.
Conclusion
We have concluded that Ebs has a significant anti-tumour effect in inducing apoptosis, and autophagy and inhibiting proliferation and migration of BCC cells, which may be achieved by inhibiting proliferation and migration of bladder cancer cells through inhibiting PI3K/AKT/mTOR pathway, activating cellular autophagy, blocking tumour cell cycle as well as inducing apoptosis and down-regulating the expression of STAT3 protein.